Colgate-Palmolive (NYSE:CL) Shares Sold by Dakota Wealth Management

Dakota Wealth Management cut its stake in Colgate-Palmolive (NYSE:CL) by 7.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,926 shares of the company’s stock after selling 715 shares during the period. Dakota Wealth Management’s holdings in Colgate-Palmolive were worth $866,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in CL. Federated Hermes Inc. grew its position in Colgate-Palmolive by 560.2% in the fourth quarter. Federated Hermes Inc. now owns 288,537 shares of the company’s stock worth $22,999,000 after acquiring an additional 244,834 shares during the period. Mitchell Sinkler & Starr PA grew its position in Colgate-Palmolive by 92.6% in the fourth quarter. Mitchell Sinkler & Starr PA now owns 45,899 shares of the company’s stock worth $3,659,000 after acquiring an additional 22,073 shares during the period. Stonehage Fleming Financial Services Holdings Ltd grew its position in Colgate-Palmolive by 57.1% in the fourth quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock worth $30,594,000 after acquiring an additional 139,429 shares during the period. D L Carlson Investment Group Inc. purchased a new position in Colgate-Palmolive in the fourth quarter worth approximately $3,269,000. Finally, Diversify Advisory Services LLC purchased a new position in Colgate-Palmolive in the first quarter worth approximately $911,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE CL traded up $0.88 during midday trading on Tuesday, reaching $102.73. 796,525 shares of the company were exchanged, compared to its average volume of 4,375,529. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 16.90. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $104.15. The stock has a fifty day simple moving average of $98.45 and a 200 day simple moving average of $92.42. The stock has a market cap of $84.28 billion, a P/E ratio of 32.23, a PEG ratio of 3.54 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same quarter last year, the company posted $0.77 earnings per share. The business’s revenue was up 4.9% on a year-over-year basis. On average, research analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date of this dividend was Friday, July 19th. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft increased their price objective on Colgate-Palmolive from $104.00 to $107.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Argus increased their price objective on Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research report on Wednesday, May 15th. TD Cowen increased their price objective on Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Tuesday, July 30th. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Finally, Stifel Nicolaus raised their price target on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, July 22nd. Eight analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $101.11.

Insider Buying and Selling at Colgate-Palmolive

In other news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the sale, the executive vice president now directly owns 10,377 shares in the company, valued at approximately $1,069,868.70. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the transaction, the executive vice president now directly owns 10,377 shares in the company, valued at approximately $1,069,868.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares of the company’s stock, valued at $529,729.24. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 41,177 shares of company stock valued at $4,245,835. 0.34% of the stock is owned by corporate insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.